FratFiles

• Save Paper

Compulsory Licensing and Parallel Imports;
Democratizing Access to Essential Medicines in Sub-Saharan African Countries


Abstract

Specifically the ideas of compulsory licensing and parallel imports are key ways to promote access to essential medicines, a poignant and particular example being in Sub-Saharan African countries. That these practices are not only legal and within established GATT and WTO rules, but are embraced in industrialized countries to apply to other products. U.S. foreign policy needs to embrace these ideas in their aggressive pressure placed on certain African countries implementing them, and join the fight on the side of public well-being and not the pharmaceutical industry.


Compulsory Licensing and Parallel Imports;
Democratizing Access to Essential Medicines in Sub-Saharan African Countries

Africa and the developing world are facing an HIV/AIDS crisis equated by the U.S. Surgeon General to the plague that decimated Europe in the fourteenth......

View the rest of this paper...

Approximate Word Count: 1359
Approximate Pages: 6 (250 words per double-spaced page)

Similar Essays

1. Compulsory Licensing And Parallel Imports
   

   Compulsory Licensing And Parallel Imports Compulsory Licensing and Parallel Imports; Democratizing Access to Essential Medicines in Sub-Saharan African Countries Abstract

2. Pharma
   

   will able to continue the production after 1jan. 2005 with out infringing the patent. * Parallel import, grey imports, "Exhaustion" of rights- parallel or grey market imports are

3. India's Economic Reforms
   

   is now needed only for a small list of industries, most of which remain subject to licensing primarily because of environmental and pollution considerations. The parallel

4. Vista
   

   company Grundig. This company sued another French company for bringing illegally (through parallel imports) into France by buying from various foreign suppliers and selling in

5. Pharmaceutical Industry In Bangladesh
   

   have to obtain licenses from patent owner to import APIs from countries that either issue compulsory license to export or otherwise permit the export of generic drugs and to permit